Generation of recombinant antibodies : use in cancer treatment

Mateo de Acosta, Cristina Maria.
La Habana; The Molecular Immunology Center, Cuba; [1997]. 22 p. tab.
Monografía en Inglés | PAHO | ID: pah-33728

Documentos relacionados

  1. Making innate sense of mRNA vaccine adjuvanticity.
  2. Identification of alternative splicing-derived cancer neoantigens for mRNA vaccine development.
  3. Comparison of Synthetic Methods and Identification of Several Artificial Antigens of Deoxynivalenol.
  4. Niosomes as Biocompatible Scaffolds for the Multivalent Presentation of Tumor-Associated Antigens (TACAs) to the Immune System.
  5. Fluorescent Artificial Antigens Revealed Extended Membrane Networks Utilized by Live Dendritic Cells for Antigen Uptake.
  6. IL-1-mediated inflammation induced by different RNA vaccines is context-specific.
  7. Mechanisms of innate and adaptive immunity to the Pfizer-BioNTech BNT162b2 vaccine.
  8. Addendum: Systems vaccinology of the BNT162b2 mRNA vaccine in humans.
  9. Assessing the feasibility of statistical inference using synthetic antibody-antigen datasets.
  10. Hecolin vaccine: long-term efficacy against HEV for a three-dose regimen.